Table 4.
Multivariate analysis (Cox proportional hazards model) for OS and RFS in patients with adenocarcinoma (N = 299)
| Variable | HR for OS (95% CI) | P value | HR for RFS (95% CI) | P value |
| Age | 1.026 (1.004–1.048) | 0.0192 | 1.020 (1.002–1.039) | 0.0317 |
| Gender | ||||
| Male versus female | 1.909 (1.265–2.880) | 0.0021 | 1.571 (1.106–2.230) | 0.0116 |
| Stage | ||||
| II versus I | 2.154 (1.346–3.445) | 0.0014 | 1.925 (1.288–2.878) | 0.0014 |
| III/IV versus I | 2.294 (1.247–4.219) | 0.0076 | 2.073 (1.198–3.585) | 0.0091 |
| Any treatment versus none | 1.056 (0.678–1.644) | 0.81 | 1.324 (0.902–1.945) | 0.15 |
| pAMPK | ||||
| Positive versus negative | 0.459 (0.307–0.688) | 0.0002 | 0.574 (0.402–0.818) | 0.0021 |
P values are calculated by Cox proportional hazards model.
OS, overall survival; RFS, recurrence-free survival; HR, hazard ratio; CI, confidence interval; pAMPK, phosphorylated AMP-activated protein kinase.